| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 12 Jul 2024 | 9 Jul 2024 |
| Deccan Health Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/07/2024 inter alia to consider and approve 1. allotment of 604333 Equity Shares pursuant to conversion of Convertible Warrants 2. any other business with the permission of the chairman Deccan Health Care Ltd - 542248 - Board Meeting Outcome for Outcome Of The Board Meeting For Conversion Of Warrants Into Equity Shares Held On 12 July 2024 The Board of Directors of the Company has allotted 6,04,333 Equity Shares of face value of Rs. 10/- each (Premium of Rs. 20/- per equity share) pursuant to exercise of 6,04,333 Convertible Warrants to M/s Focal Ventures Private Limited. Read less.. (As Per BSE Announcement Dated on 12.07.2024) | ||
| Board Meeting | 29 May 2024 | 22 May 2024 |
| Deccan Health Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2024 inter alia to consider and approve the Audited Financial Results for the year ended March 31 2024 and Change in Registered Office of the Company within Local Limit. Board of Directors of the Company at this meeting approved the Audited Financial Results and change in the registered office address within the local limits of the city. Financial Results for the Quarter and Year ended 31st March 2024 Change in Registered office within local limits of the City. (As Per BSE Announcement Dated on 29.05.2024) | ||
| Board Meeting | 11 Mar 2024 | 6 Mar 2024 |
| Deccan Health Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/03/2024 inter alia to consider and approve 1. Appointment(s)/Recruitment(s) of Additional Director(s). 2. Draft Notice of Postal Ballot. 3. Appointment of Scrutinizer and e-voting agency for the postal ballot process. 4. Any other matter incidental and ancillary related to aforesaid above matters. 5. To consider and discuss any other business with the permission of the chairman. With reference to our Intimation vide letter dated Wednesday, March 06, 2024 we wish to inform you that the Board Directors of the Company in its meeting held today i.e. Monday, March 11, 2024 have Inter-alia approved the agenda attached herewith (As per BSE Announcement Dated on 11/03/2024) | ||
| Board Meeting | 6 Feb 2024 | 29 Jan 2024 |
| Deccan Health Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/02/2024 inter alia to consider and approve 1. To consider and approve Unaudited Financial Results (Standalone & Consolidated) along with the Limited Review Report thereon of the Company for the Quarter ended December 31 2023. 2. Approval of Appointment(s)/Recruitment(s) of Additional Director(s). 3. Appointment of Internal Auditor for the F.Y. 2023-24. 4. To consider and discuss any other business with the permission of the chairman. As per the pdf attached with the announcement Appointment of Additional Directors (Independent and Non-Independent Category) (As Per BSE Announcement Dated on: 06/02/2024) | ||
| Board Meeting | 21 Dec 2023 | 18 Dec 2023 |
| Deccan Health Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/12/2023 inter alia to consider and approve 1. To Discuss Deliberate and Approve Potential Opportunities associated in Foreign Market and Incorporating Subsidiaries accordingly if required and deemed necessary. 2. Appointment(s)/Recruitment(s) of Additional Director(s). 3. To consider and discuss any other business with the permission of the chairman. Kindly take the above information on your records. With reference to our Intimation vide letter dated Monday, December 18, 2023 we wish to inform you that the Board Directors of the Company in its meeting held today i.e. Thursady, December 21, 2023 through Video Conferencing/OAVM have Inter-alia; 1. Discussed the opportunities associated in the foreign market and decided to incorporate subsidiaries of Deccan Health Care Limited, initially in USA and UAE for the presence in the International market subject to the approval of shareholders. Further details of General Meeting will be shared at the earliest. 2. Discussed the profile of the candidate on the recommendation of Nomination and Remunaration Committee and agreed to complete the requirements on the documentation part. The board will take up this agenda in next board meeting for the confirmation after completing the procedural requirement as needed. Further the details of candidate with profile will be shared after the approval of Board in upcoming Board Meeting. (As Per BSE Announcement Dated on 21/12/2023) | ||
| Board Meeting | 11 Nov 2023 | 3 Nov 2023 |
| Deccan Health Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2023 inter alia to consider and approve 1. To consider and approve Unaudited Financial Results (Standalone & Consolidated) along with the Limited Review Report thereon of the Company for the Quarter ended September 30 2023. 2. Any other business with the permission of the Chair. In this connection and in continuation of our intimation regarding Closure of Trading Window for the Insiders of the Company the trading window for dealing in the securities of the Company is already closed for the Insiders of the Company since October 01 2023 and the same shall open 48 hours after declaration of Financial Results of the company. With reference to our Intimation vide letter dated Friday, November 03, 2023 we wish to inform you that the Board Directors of the Company in its meeting held today i.e. Saturday, November 11, 2023 through Video Conferencing/OAVM have Inter-alia; 1. Considered and Approved the Standalone Unaudited Financial Results of the Company for the quarter ended September 30, 2023 along with the Limited Review Report. 2. Considered and Approved the Consolidated Unaudited Financial Results of the Company for the quarter ended on September 30, 2023 along with the Limited Review Report. The Board Meeting commenced at 11:30 AM and concluded at 11:50 AM (As Per BSE Announcement Dated on 11.11.2023) | ||
| Board Meeting | 12 Oct 2023 | 9 Oct 2023 |
| Deccan Health Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/10/2023 inter alia to consider and approve 1. To allot Equity Shares and/or Convertible Warrants on the basis of preferential allotment to Promoter/Persons belong to promoter Group and Person other than Promoters/Promoters Group of the Company. 2. Any other matter incidental and ancillary related to aforesaid above matters. 3. To consider and discuss any other Business with the permission of the Chairman. 1. Pursuant to the approval of the Members and receipt of Cash consideration in full, the Company has approved the allotment of 33,33,000 Equity Shares of Rs. 10 each of the Company, at a price of Rs. 30/- per share to person other than promoter and Promoter Group 2. Pursuant to the approval of the Members and Pursuant to the receipt of the 25% of Issue Price / subscription money, the Company has considered and approved the allotment of 53,73,000 Convertible Warrants at a price of Rs. 30/- per Warrants to Promoter and Person other than Promoter and Promoter Group The Board Meeting commenced at 03:30 PM and concluded at 03:45 PM. (As per BSE Announcement Dated on 12/10/2023) | ||
| Board Meeting | 1 Sep 2023 | 1 Sep 2023 |
| The Board Directors of the Company in its meeting held today i.e. Friday, September 01, 2023 through Video Conferencing/OAVM have Inter-alia considered and approved the business as attached herewith. | ||
| Board Meeting | 28 Aug 2023 | 22 Aug 2023 |
| Deccan Health Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/08/2023 ,inter alia, to consider and approve 1. Raising of funds by way of Issue of Equity Shares /convertible warrants to Promoters / Promoters Group and person(s) other than promoters / Promoter Group on preferential basis, subject to obtaining approval of the shareholders of the Company. 2. Increase in authorized capital (if required) 3. Any other matter incidental and ancillary related to aforesaid above matters. 4. To consider and discuss any other Business with the permission of the Chairman. Further, the Trading Window will be closed with immediate effect and will continue to remain close till 48 hours after the submission of outcome of the Board Meeting to be held on Monday, August 28, 2023. Accordingly, all the designated persons /insiders of the Company are hereby informed that not to trade in the equity shares of the Company during the aforesaid period of closure of trading window we wish to inform you that the Board Directors of the Company in its meeting held today i.e. Monday, August 28, 2023 through Video Conferencing/OAVM have Inter-alia considered and approved the following; 1. Issuance of Equity Shares and Warrants by way of Preferential Allotment 2. Increase in Authorised Share Capital of the Company and consequent alteration of Memorandum of Association 3. Convening Shareholders Approval through Postal Ballot. 4. The Board appointed Ms. Monika Bhatia (M/s M R Bhatia & Co), Company Secretary in practice as a scrutinizer to scrutinize the votes cast by the members through remote e-voting for Postal Ballot process in a fair and transparent manner. The Board Meeting commenced at 04:30 PM and concluded at 05:00 PM. (As per BSE Announcement Dated on 28/08/2023) | ||
| Board Meeting | 14 Aug 2023 | 7 Aug 2023 |
| Deccan Health Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2023 inter alia to consider and approve 1. Unaudited Financial Results (Standalone & Consolidated) along with the Limited Review Report thereon of the Company for the First Quarter ended June 30 2023. 2. To deliberate discuss and potentially endorse the enhancement of financial resources to support the expansion of offerings/New Products and the geographic reach of the online stores namely www.beyoungstore.com and www.nutridecc.in. This entails securing funds through the preferential route utilizing various avenues such as equity shares and/or warrants in accordance with the provisions specified under Section 42 & 62 of the Companies Act 2013 and in alignment with the relevant regulations delineated in Chapter V of the SEBI (Issue of Capital and Disclosure Requirements) Regulations 2018. The proposal shall extend to both existing and potential investors including promoters contingent upon obtaining the requisite approvals. 3. Any other business with the permission of the Chair. | ||
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Securities Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2024, IIFL Securities Ltd. All Rights Reserved
www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.
Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
